Author: Wang, Jin; Jiang, Mengmeng; Chen, Xin; Montaner, Luis J.
Title: Cytokine storm and leukocyte changes in mild versus severe SARSâ€CoVâ€2 infection: Review of 3939 COVIDâ€19 patients in China and emerging pathogenesis and therapy concepts Cord-id: r4vobu5w Document date: 2020_6_13
ID: r4vobu5w
Snippet: Clinical evidence indicates that the fatal outcome observed with severe acute respiratory syndromeâ€coronavirusâ€2 infection often results from alveolar injury that impedes airway capacity and multiâ€organ failure—both of which are associated with the hyperproduction of cytokines, also known as a cytokine storm or cytokine release syndrome. Clinical reports show that both mild and severe forms of disease result in changes in circulating leukocyte subsets and cytokine secretion, particularly
Document: Clinical evidence indicates that the fatal outcome observed with severe acute respiratory syndromeâ€coronavirusâ€2 infection often results from alveolar injury that impedes airway capacity and multiâ€organ failure—both of which are associated with the hyperproduction of cytokines, also known as a cytokine storm or cytokine release syndrome. Clinical reports show that both mild and severe forms of disease result in changes in circulating leukocyte subsets and cytokine secretion, particularly ILâ€6, ILâ€1β, ILâ€10, TNF, GMâ€CSF, IPâ€10 (IFNâ€induced protein 10), ILâ€17, MCPâ€3, and ILâ€1ra. Not surprising, therapies that target the immune response and curtail the cytokine storm in coronavirus 2019 (COVIDâ€19) patients have become a focus of recent clinical trials. Here we review reports on leukocyte and cytokine data associated with COVIDâ€19 disease in 3939 patients in China and describe emerging data on immunopathology. With an emphasis on immune modulation, we also look at ongoing clinical studies aimed at blocking proinflammatory cytokines; transfer of immunosuppressive mesenchymal stem cells; use of convalescent plasma transfusion; as well as immunoregulatory therapy and traditional Chinese medicine regimes. In examining leukocyte and cytokine activity in COVIDâ€19, we focus in particular on how these levels are altered as the disease progresses (neutrophil NETosis, macrophage, T cell response, etc.) and proposed consequences to organ pathology (coagulopathy, etc.). Viral and host interactions are described to gain further insight into leukocyte biology and how dysregulated cytokine responses lead to disease and/or organ damage. By better understanding the mechanisms that drive the intensity of a cytokine storm, we can tailor treatment strategies at specific disease stages and improve our response to this worldwide public health threat.
Search related documents:
Co phrase search for related documents- aberrant activation and acute infection: 1, 2, 3
- aberrant activation and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- aberrant activation and adaptive immune response: 1, 2, 3, 4
- aberrant activation and additional study: 1
- aberrant net and acute ards respiratory distress syndrome: 1
- acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and additional study: 1, 2, 3, 4, 5
- acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute infection and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory sars syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory sars syndrome and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
Co phrase search for related documents, hyperlinks ordered by date